The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AEROVATE THERAPEUTICS INC | COM | 008064107 | 386 | 13,190 | SH | SOLE | N/A | 13,190 | 0 | 0 | |
AMPLITUDE INC | COM CL A | 03213A104 | 229 | 18,944 | SH | SOLE | N/A | 18,944 | 0 | 0 | |
CONFLUENT INC | CLASS A COM | 20717M103 | 1,450 | 65,191 | SH | SOLE | N/A | 65,191 | 0 | 0 | |
DISC MEDICINE INC | COM | 254604101 | 2,198 | 110,488 | SH | SOLE | N/A | 110,488 | 0 | 0 | |
EVELO BIOSCIENCES INC | COM | 299734103 | 183 | 113,850 | SH | SOLE | N/A | 113,850 | 0 | 0 | |
RAPT THERAPEUTICS INC | COM | 75382E109 | 1,453 | 73,383 | SH | SOLE | N/A | 73,383 | 0 | 0 | |
TENAYA THERAPEUTICS INC | COM | 87990A106 | 587 | 291,828 | SH | SOLE | N/A | 291,828 | 0 | 0 | |
SURROZEN INC | COM | 86889P109 | 419 | 718,950 | SH | SOLE | N/A | 718,950 | 0 | 0 | |
SURROZEN INC | *W EXP 08/01/2 | 86889P117 | 3 | 33,333 | SH | SOLE | N/A | 33,333 | 0 | 0 | |
BERKSHIRE HATHAWAY INC DEL | CL A | 084670108 | 35,622 | 76 | SH | SOLE | N/A | 76 | 0 | 0 | |
BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 340 | 1,100 | SH | SOLE | N/A | 1,100 | 0 | 0 | |
TRANSDIGM GROUP INC | COM | 893641100 | 1,954 | 3,103 | SH | SOLE | N/A | 3,103 | 0 | 0 | |
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 2,412 | 192,973 | SH | SOLE | N/A | 192,973 | 0 | 0 | |
VOR BIOPHARMA INC | COM | 929033108 | 611 | 91,910 | SH | SOLE | N/A | 91,910 | 0 | 0 | |
XILIO THERAPEUTICS INC | COM | 98422T100 | 672 | 249,635 | SH | SOLE | N/A | 249,635 | 0 | 0 |